1,379
Views
9
CrossRef citations to date
0
Altmetric
Review Article

Ceramide pathway: A novel approach to cancer chemotherapy

, &
Pages 237-244 | Received 10 Aug 2018, Accepted 23 Oct 2018, Published online: 06 Mar 2019

References

  • B.J.PettusC.E.ChalfantY.A.HannunCeramide in apoptosis: an overview and current perspectivesBiochim Biophys Acta15852002114125
  • B.OgretmenY.A.HannunBiologically active sphingolipids in cancer pathogenesis and treatmentNat Rev Cancer42004604616
  • C.P.ReynoldsaB.J.MaureraR.N.KolesnickCeramide synthesis and metabolism as a target for cancer therapyCancer Lett2062004169180
  • L.OuyangZ.ShiS.ZhaoF.T.WangT.T.Zhouet al.Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosisCell Prolif452012487498
  • S.ElmoreApoptosis: a review of programmed cell deathToxicol Pathol352007495516
  • N.J.PyneS.PyneSphingosine 1-phosphate, and cancerNat Rev Cancer102010489503
  • T.H.BeckhamJ.C.ChengS.T.MarrisonJ.S.NorrisX.LiuInterdiction of sphingolipid metabolism to improve standard cancer therapiesAdv Cancer Res1172013136
  • D.PizziraniC.PaqliucaN.RealiniD.BranduardiG.BottegoniDiscovery of a new class of highly potent inhibitors of acid ceramidase: synthesis and structure-activity relationship (SAR)J Med Chem56201335183530
  • X.M.YinSignal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathwaysCell Res102000161167
  • M.E.GuicciardiM.LeistG.J.GoresLysosomes in cell deathOncogene23200428812890
  • R.Hage-SleimanM.O.EsmerianH.KobeissyG.Dbaibop53 and ceramide as collaborators in the stress responseInt J Mol Sci14201349825012
  • G.DewsonR.M.KluckMechanisms by which Bak and Bax permeabilise mitochondria during apoptosisJ Cell Sci122200928012808
  • J.E.ChipukD.R.GreenHow do BCL-2 proteins induce mitochondrial outer membrane permeabilization?Trends Cell Biol182008157164
  • S.J.KorsmeyerM.C.WeiM.SaitoS.WeilerK.J.OhP.H.SchlesingerPro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome cCell Death Differ7200011661173
  • Y.LiS.LiX.QinW.HouH.DongL.Yaoet al.The pleiotropic roles of sphingolipid signaling in autophagyCell Death Dis520141245
  • M.A.LevyH.FutermanMammalian ceramide synthasesIUBMB Life622010347356
  • C.R.GaultL.M.ObeidY.A.HannunAn overview of sphingolipid metabolism: from synthesis to breakdownAdv Exp Med Biol6882010123
  • Y.A.C.LubertoK.M.ArgravesEnzymes of sphingolipid metabolism: from modular to integrative signalingBiochemistry40200148934903
  • S.A.F.MoradJ.C.LevinS.F.TanT.E.FoxD.J.FeithM.C.CabotNovel off-target effect of tamoxifen - inhibition of acid ceramidase activity in cancer cellsBiochim Biophys Acta1831201316571664
  • R.KolesnickThe therapeutic potential of modulating the ceramide/sphingomyelin pathwayJ Clin Invest1200238
  • S.Y.V.ChanA.L.HilchieM.G.BrownR.AndersonD.W.HoskinApoptosis induced by intracellular ceramide accumulation in MDA-MB-435 breast carcinoma cells is dependent on the generation of reactive oxygen speciesExp Mol Pathol822007111
  • A.BaiC.MaoR.W.JenkinsZ.M.SzulcA.BielawskaY.A.HannunAnticancer actions of lysosomally targeted inhibitor, LCL521, of acid ceramidasePLoS One122017 e0177805
  • N.C.ZitomerT.MitchellK.A.VossG.S.BondyS.T.Pruettet al.Ceramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxysphinganine: a novel category of bioactive 1-deoxysphingoid bases and 1-deoxydihydroceramides biosynthesized by mammalian cell lines and animalsJ Biol Chem284200947864795
  • M.BektasC.E.OrfanosC.C.GeilenDifferent vitamin D analogues induce sphingomyelin hydrolysis and apoptosis in the human keratinocyte cell line HaCaTCell Mol Biol (Noisy-le-grand)462000111119
  • A.BettaïebI.PloV.Mansat-De MasA.Quillet-MaryT.Levadeet al.Daunorubicin-and mitoxantrone-triggered phosphatidylcholine hydrolysis: implication in drug-induced ceramide generation and apoptosisMol Pharmacol551999118125
  • N.BeckmannD.SharmaE.GulbinsK.A.BeckerB.EdelmannInhibition of acid sphingomyelinase by tricyclic antidepressants and analogonsFront Physiol52014331
  • M.Mashhadi Akbar BoojarM.Mashhadi Akbar BoojarS.GolmohammadI.BahrehbarData on cell survival, apoptosis, ceramide metabolism and oxidative stress in A-494 renal cell carcinoma cell line treated with hesperetin and hesperetin-7-O-acetateData in Brief202018596601
  • V.Gouazé-AnderssonM.FlowersR.KarimiG.FabriásA.Delgadoet al.Inhibition of acid ceramidase by a 2-substituted aminoethanol amide synergistically sensitizes prostate cancer cells to N-(4-hydroxyphenyl) retinamideProstate71201110641073
  • S.P.SardiC.VielJ.ClarkeC.M.TreleavenA.M.Richardset al.Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy modelsProc Natl Acad Sci USA114201726992704
  • M.Mashhadi Akbar BoojarM.HassanipourS.Ejtemaei MehrM.Mashhadi Akbar BoojarA.R.DehpourNew aspects of Silibinin stereoisomers and their 3-O-galloyl derivatives on cytotoxicity and ceramide metabolism in Hep G2 hepatocarcinoma cell lineIran J Pharm Res152016421433
  • F.M.GonA.AlonsoSphingomyelinases: enzymology and membrane activityFEBS Lett53120023846
  • N.Andrieu-AbadieT.LevadeSphingomyelin hydrolysis during apoptosisBiochim Biophys Acta15852002126134
  • N.MarchesiniY.A.HannunAcid and neutral sphingomyelinases: roles and mechanisms of regulationBiochem Cell Biol8220042744
  • J.H.ParkE.H.SchuchmanAcid ceramidase and human diseaseBiochim Biophys Acta1758200621332138
  • X.LiuJ.C.ChengL.S.TurnerS.ElojeimyT.H.BeckhamA.Bielawskaet al.Acid ceramidase up-regulation in prostate cancer: role in tumor development and implications for therapyExpert Opin Ther Targets13200914491458
  • M.Mashhadi Akbar BoojarM.Mashhadi Akbar BoojarS.GolmohammadM.NikkhahYazdiCeramide generation as a novel biological mechanism for chemo-preventive and cytotoxic effects of hesperidin on HT-144 melanoma cells. Beni-Suef UniversityJ Basic Appl Sci2018 IN Press
  • D.ProkschJ.J.KleinC.ArenzPotent inhibition of acid ceramidase by novel B-13 analoguesJ Lipids201120118
  • Y.Y.LiuY.T.LiCeramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistanceAdv Cancer Res11720145989
  • J.F.LiS.J.ZhengL.L.WangS.LiuF.Renet al.Glucosylceramide synthase regulates the proliferation and apoptosis of liver cells in vitro by Bcl-2/Bax pathwayMol Med Rep16201773557360
  • M.KartalG.SaydamF.SahinY.BaranResveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cellsNutr Cancer632011637644
  • A.Gomez-MuñozThe role of ceramide 1-phosphate in tumor cell survival and disseminationAdv Cancer Res1402018217234
  • K.KitataniJ.Idkowiak-BaldysJ.BielawskiR.W.JenkinsC.E.Senkalet al.Protein kinase C-induced activation of a ceramide/protein phosphatase 1 pathway leading to dephosphorylation of p38 MAPKJ Biol Chem281320063679336802
  • R.KolesnickZ.FuksRadiation and ceramide-induced apoptosisOncogene22200358975906
  • S.LahiriA.H.FutermanThe metabolism and function of sphingolipids and glycosphingolipidsCell Mol Life Sci64200722702284
  • K.PalmanoA.RowanR.GuillermoJ.GuanP.M.JarrowThe role of gangliosides in neurodevelopmentNutrients7201538913913
  • J.MatsudaM.T.VanierI.PopaJ.PortoukalianK.SuzukiGD3- and O-acetylated GD3-gangliosides in the GM2 synthase-deficient mouse brain and their immunohistochemical localizationProc Jpn Acad Ser B Phys Biol Sci822006189196
  • P.HerseyO.JamalC.HendersonI.ZardawiG.D'AlessandroExpression of the gangliosides GM3, GD3 and GD2 in tissue sections of normal skin, naevi, primary and metastatic melanomaInt J Cancer411988336343
  • S.CaughlinS.MaheshwariN.WeishauptK.K.YeungD.F.CechettoS.N.WhiteheadAge-dependent and regional heterogeneity in the long-chain base of A-series gangliosides observed in the rat brain using MALDI ImagingSci Rep7201716135
  • R.B.ChanA.J.PerotteB.ZhouC.LiongE.J.ShorrK.S.Marderet al.Elevated GM3 plasma concentration in idiopathic Parkinson's disease: a lipidomic analysisPLoS One122017 e0172348
  • A.Di PardoV.MaglioneSphingolipid metabolism: a new therapeutic opportunity for brain degenerative disordersFront Neurosci17122018249
  • Y.IlanCompounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistanceAm J Physiol Gastrointest Liver Physiol3102016G1102G1117
  • B.OgretmenSphingolipid metabolism in cancer signalling and therapyNat Rev Cancer1820183350
  • M.C.PetersenG.I.ShulmanRoles of diacylglycerols and ceramides in hepatic insulin resistanceTrends Pharmacol Sci382017649665